Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
1.640
+0.010 (0.61%)
At close: Dec 5, 2025, 4:00 PM EST
1.660
+0.020 (1.22%)
After-hours: Dec 5, 2025, 4:32 PM EST
Ensysce Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 4.49 | 5.21 | 2.23 | 2.52 | 3.53 | 3.93 | |
| Revenue Growth (YoY) | 1.51% | 133.58% | -11.61% | -28.54% | -10.17% | 122.86% | |
| Cost of Revenue | 10.57 | 7.22 | 7.59 | 19.84 | 4.69 | 4.39 | |
| Gross Profit | -6.08 | -2.01 | -5.36 | -17.31 | -1.16 | -0.46 | |
| Selling, General & Admin | 4.96 | 4.72 | 5.36 | 6.91 | 18.71 | 1.15 | |
| Operating Expenses | 4.96 | 4.72 | 5.36 | 6.91 | 18.71 | 1.15 | |
| Operating Income | -11.04 | -6.73 | -10.72 | -24.22 | -19.87 | -1.61 | |
| Interest Expense | -0.02 | -1.29 | -0.35 | -1.25 | -3.22 | -1 | |
| Other Non Operating Income (Expenses) | 0.09 | 0.03 | 0.3 | -0.53 | -2.91 | 2.45 | |
| EBT Excluding Unusual Items | -10.97 | -7.99 | -10.77 | -26 | -26 | -0.16 | |
| Other Unusual Items | - | - | 0.15 | 1.79 | -3.15 | - | |
| Pretax Income | -10.97 | -7.99 | -10.63 | -24.21 | -29.15 | -0.16 | |
| Earnings From Continuing Operations | -10.97 | -7.99 | -10.63 | -24.21 | -29.15 | -0.16 | |
| Minority Interest in Earnings | 0 | 0 | 0.01 | 0.04 | 0.06 | 0.22 | |
| Net Income | -10.97 | -7.99 | -10.61 | -24.17 | -29.08 | 0.06 | |
| Preferred Dividends & Other Adjustments | - | 0 | 0.01 | 0.91 | 0.8 | - | |
| Net Income to Common | -10.97 | -7.99 | -10.63 | -25.09 | -29.89 | 0.06 | |
| Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | - | - | |
| Shares Outstanding (Diluted) | 2 | 1 | 0 | 0 | - | - | |
| Shares Change (YoY) | 347.04% | 362.24% | 1158.33% | - | - | - | |
| EPS (Basic) | -5.67 | -11.45 | -70.40 | -2091.33 | - | - | |
| EPS (Diluted) | -5.67 | -11.45 | -70.40 | -2091.33 | - | - | |
| Gross Margin | -135.44% | -38.57% | -240.17% | - | -32.82% | -11.66% | |
| Operating Margin | -245.89% | -129.18% | -480.52% | -959.91% | -562.71% | -41.04% | |
| Profit Margin | -244.49% | -153.31% | -476.39% | -994.12% | -846.37% | 1.44% | |
| EBITDA | - | - | - | -24.22 | -19.87 | -1.61 | |
| EBITDA Margin | - | - | - | - | - | -41.03% | |
| D&A For EBITDA | - | - | - | 0 | 0 | 0 | |
| EBIT | -11.04 | -6.73 | -10.72 | -24.22 | -19.87 | -1.61 | |
| EBIT Margin | -245.89% | -129.18% | - | - | - | -41.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.